Loading
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (3 ops.)
Latest filing published 14 Aug 2026 for Caris Life Sciences, Inc.. Read the official filing
Filing timeline
BuySaleJoseph E. Gilliam
Insider track record
Disclosed buys
0
Disclosed sells
3
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Joseph E. Gilliam: trading record in brief
Filings by Joseph E. Gilliam span 2 companies, the busiest being GLAUKOS Corp and Caris Life Sciences, Inc. We count 63 filings; the first trade dates from 3 May 2021 and the latest from 14 August 2026.
No open-market purchase appears, only 3 sales worth €10.8M. Besides market trades, the filings include 33 share grants and 27 option exercises. In 2026 alone, the filings show no purchases and 2 sales.
The record was last updated on 14 August 2026 with a share grant in Caris Life Sciences, Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. Section 16 rules allow two business days to file each Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Joseph E. Gilliam
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations63 total
13,192 shares0Common StockSEC:0001705850-26-000025:0
10,000 shares@ US$48.460.0045% mcap1.2% of flowCommon StockSEC:0001705850-26-000022:0
20,000 shares@ US$55.180.010% mcap2.7% of flowCommon StockSEC:0001705850-26-000022:1
20,000 shares@ US$55.180.010% mcap2.7% of flowCommon StockSEC:0001705850-26-000022:2
10,000 shares@ US$48.460.0045% mcap1.2% of flowCommon StockSEC:0001705850-26-000022:3
27,963 shares@ US$178.890.047% mcap12.3% of flowCommon StockSEC:0001705850-26-000022:4
32,037 shares@ US$180.490.054% mcap14.3% of flowCommon StockSEC:0001705850-26-000022:5
1,056 sharesCommon StockSEC:0001705850-26-000020:0
3,169 shares@ US$109.602.5% of flowCommon StockSEC:0001705850-26-000016:0
5,829 shares0Common StockSEC:0001705850-26-000014:0
2,804 shares@ US$106.842.3% of flowCommon StockSEC:0001705850-26-000012:0
1,189 shares@ US$98.940.9% of flowCommon StockSEC:0001705850-26-000010:0
2,462 shares@ US$97.021.8% of flowCommon StockSEC:0001705850-26-000008:0
1,057 shares@ US$119.170.8% of flowCommon StockSEC:0001705850-26-000006:0
10,498 shares@ US$55.183.6% of flowCommon StockSEC:0001705850-26-000004:0
4,502 shares@ US$55.180.0033% mcap8.9% of flowCommon StockSEC:0001705850-26-000002:0
19,340 shares@ US$90.0011.5% of flowCommon StockSEC:0001705850-25-000009:0
1,056 shares@ US$84.690.7% of flowCommon StockSEC:0001705850-25-000007:0
3,884 shares0Common StockSEC:0001705850-25-000005:0
1,057 shares@ US$96.970.8% of flowCommon StockSEC:0001415889-25-015022:0
1,922 shares@ US$97.091.5% of flowCommon StockSEC:0001415889-25-009798:0
13,429 shares@ US$107.6111.5% of flowCommon StockSEC:0001415889-25-009125:0
3,888 shares0Common StockSEC:0001415889-25-008254:0
964 shares@ US$138.931.1% of flowCommon StockSEC:0001415889-25-000248:0
1,053 shares@ US$39.100.3% of flowCommon StockSEC:0001415889-24-030120:0
25 of 63 declarations
